Recombinant DNA Advisory Committee


Also found in: Acronyms.

Recombinant DNA Advisory Committee

 [re-kom´bĭ-nant]
RAC, a committee composed of scientists and ethicists, set up to review human gene therapy research in order to protect patients from unethical practices, procedures, and research. All research involving human gene therapy must comply with both the Common Federal Rule and the RAC.
Mentioned in ?
References in periodicals archive ?
The NIH Recombinant DNA Advisory Committee voted to allow a group led by Edward H.
The FDA's clearance to proceed with a Phase I safety trial came following the agency's completed review of the study's clinical design and the unanimous vote of the Recombinant DNA Advisory Committee (RAC) on March 15, 2004, that the first human clinical study of Oragenics Replacement Therapy be carried out under the protocol proposed by the company.
Ando served as a member of the Recombinant DNA Advisory Committee (RAC) and the Adenoviral Safety Committee for the National Institutes of Health (NIH).
Rosenberg began the new therapy just hours after receiving approval from the agency's Recombinant DNA Advisory Committee and the NIH director.
OTCBB:NRGX), a developer of proprietary therapies for treating central nervous system disorders, today announced that it has received a favorable review of its clinical trial protocol presented to the National Institute of Health's Recombinant DNA Advisory Committee (RAC) for NLX-E201, the Company's gene therapy product for the treatment of intractable temporal lobe epilepsy.
Since 2000, he has served as the Chairman of the Recombinant DNA Advisory Committee (RAC) at the National Institutes of Health.
Wilson at the University of Michigan Medical Center in Ann Arbor received the nod from the NIH Recombinant DNA Advisory Committee to administer genetically engineered liver cells to thee patients with familial hypercholesterolemia.
U) announced today that the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health (NIH) has voted unanimously that the first human clinical study of Oragenics' Replacement Therapy for the treatment of dental caries should be carried out under the protocol proposed by the company.
presented its proposed clinical protocol for AV201 for the treatment of advanced Parkinson's disease at the Friday, October 17, meeting of the National Institutes of Health (NIH) Recombinant DNA Advisory Committee (RAC).
The Houston team must also win approval from the NIH's Recombinant DNA Advisory Committee, which meets May 31, and from the Food and Drug Administration.
GenStar Therapeutics, (AMEX:GNT), a biotechnology company developing gene therapy products for the treatment of hemophilia A, prostate cancer, and AIDS, Friday reported that the company's gene therapy clinical protocol for hemophilia A had been reviewed by the National Institutes of Health Recombinant DNA Advisory Committee.
Both proposals passed review by the Recombinant DNA Advisory Committee (RAC), a panel of scientists, ethics experts and laypersons charged with advising the National Institutes of Health (NIH) on genetic engineering.

Full browser ?